Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of liraglutide on body weight in obese subjects without diabetes
2006-004481-13Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liraglutide in obesity (5 arms), sponsored by Novo Nordisk. Primary endpoint: Body weight loss. Started Sep 2006; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on 2006-004481-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004481-13.